4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-17-066819
Chief Operating Officer gave up 889 shares (to pay taxes)
- Chief Operating Officer acquired 2,925 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Powala Christopher Chief Operating Officer | 2017-12-15 | Option exercise | +1,300 | 132,865 | D: show line 1 in the form | ||
| Powala Christopher Chief Operating Officer | 2017-12-15 | Shares withheld for taxes | −395 | $24.23 | $9,571 | 132,470 | D: show line 2 in the form |
| Powala Christopher Chief Operating Officer | 2017-12-18 | Option exercise | +1,625 | 134,095 | D: show line 3 in the form | ||
| Powala Christopher Chief Operating Officer | 2017-12-18 | Shares withheld for taxes | −494 | $24.12 | $11,915 | 133,601 | D: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Powala Christopher Chief Operating Officer | 2017-12-15 | Option exercise · Restricted Stock Units | −1,300 | 9,100 | D: show line 5 in the form | |||||
| Powala Christopher Chief Operating Officer | 2017-12-18 | Option exercise · Restricted Stock Units | −1,625 | 3,250 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…